Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
NOVN:SWX since
Alnylam Pharmaceuticals IncRumoured18 Nov 202118 Nov 2021Rumoured-3.48%--
Arctos Medical AGDeal completed21 Sep 202121 Sep 2021Deal completed-4.71%--
Cadent TherapeuticsAnnounced17 Dec 202017 Dec 2020Announced-8.63%770.00m
Data delayed at least 15 minutes, as of Dec 03 2021 16:39 GMT.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.